Search

everythinglearnresearchcommunity

for

Search:↓

Transmasculine individuals on testosterone therapy need tailored contraception and fertility advice due to unique risks and benefits of each contraceptive method.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

A certain mutation in the fetal alpha 5-reductase gene is linked to a higher risk of late miscarriage.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Women with PCOS often have sexual problems, and treating these issues early can improve satisfaction and reduce healthcare costs.

Girls conceived via assisted reproductive technologies show early puberty signs and larger ovaries.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.

Women with acne and PCOS should be checked for insulin resistance and related symptoms.

High doses of testosterone disrupt hormone levels and receptor expression in the uterus, affecting fertility.

Heavily hunted wolves have higher stress and reproductive hormone levels.

Using anabolic-androgenic steroids can harm men's reproductive health and increase the risk of heart problems and death.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Doctors are preparing to potentially perform uterus transplants in transgender women, considering technical, hormonal, and ethical factors.

Myo-inositol-based treatments greatly improve pregnancy chances for women with PCOS.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

Menstrual abnormalities in PCOS women may not greatly affect their metabolic and hormonal profile.

Choosing the right starting dose of Clomiphene Citrate for ovulation induction in PCOS women is challenging; higher BMI and hormone levels may indicate resistance to the standard dose.

Young women with high male hormone levels or PCOS often feel more psychological distress and have a lower quality of life.

Titanium dioxide nanoparticles may harm the male reproductive system.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

People with reproductive, thyroid disorders, and type 2 diabetes can experience voice changes, but more research is needed to understand this better.